{
    "eid": "2-s2.0-85104046992",
    "title": "Non-vitamin k antagonist oral anticoagulants provide less adverse renal outcomes than warfarin in non-valvular atrial fibrillation: A systematic review and metaanalysis",
    "cover-date": "2021-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Cardiology and Cardiovascular Medicine",
            "@code": "2705",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Acute kidney injury",
        "End-stage renal disease",
        "NOACs",
        "Non-valvular atrial fibrillation",
        "Renal outcomes",
        "Warfarin"
    ],
    "authors": [
        "Patita Sitticharoenchai",
        "Kullaya Takkavatakarn",
        "Smonporn Boonyaratavej",
        "Kearkiat Praditpornsilpa",
        "Somchai Eiam-Ong",
        "Paweena Susantitaphong"
    ],
    "citedby-count": 10,
    "ref-count": 52,
    "ref-list": [
        "Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993\u2013 2007",
        "A review of atrial fibrillation",
        "Atrial fibrillation pathophysi-ology: implications for management",
        "2019 AHA/ ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society in Collaboration with the Society of Thoracic Surgeions",
        "The 2018 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation",
        "A review of oral anticoagulants in patients with atrial fibrillation",
        "Warfarin related acute kidney injury: a case report",
        "Warfarin-related ne-phropathy",
        "Renal outcomes in anticoagulated patients with atrial fibrillation",
        "Rivaroxaban\u2019s impact on renal decline in patients with nonvalvular atrial fibrillation: a US marketscan claims database anal-ysis",
        "The risk of acute kidney injury in Asians treated with apix-aban, rivaroxaban, dabigatran, or warfarin for non-valvular atrial fibrilla-tion: a nationwide cohort study in Taiwan",
        "Dabigatran-induced acute interstitial nephritis: an important complication of newer oral anticoagu-lation agents",
        "Warfarin and vascular calcification",
        "Evaluation of the vascular protective effects of new oral anticoagu-lants in high-risk patients with atrial fibrillation (PREFER-AF): study protocol for a randomized controlled trial",
        "Anti-inflammatory and antiplatelet effects of non-vitamin K antagonist oral anticoagulants in acute phase of ischemic stroke patients",
        "Risk of renal failure with the non-vitamin K antagonist oral anticoagulants: systematic review and meta-analysis",
        "Decreased risk of renal impairment in atrial fibrillation patients receiv-ing non-vitamin K antagonist oral anticoagulants: a pooled analysis of randomized controlled trials and real-world studies",
        "Dabigatran versus warfarin in patients with atrial fibrillation",
        "Apixaban versus warfarin in patients with atrial fibrillation",
        "Rivaroxaban versus war-farin in nonvalvular atrial fibrillation",
        "Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation \u2013 the J-ROCKET AF study",
        "Edoxaban versus warfarin in patients with atrial fibrillation",
        "Rationale and design of the X-VERT trial: a comparison of oral rivaroxaban once daily with dose-adjusted vitamin K antagonists in patients with nonvalvu-lar atrial fibrillation undergoing elective cardioversion",
        "An open-label, randomized, controlled, multicenter study exploring two treatment strategies of ri-varoxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI)",
        "Changes in renal function in patients with atrial fibrillation: an analysis from the RE-LY Trial",
        "On-treatment outcomes in patients with worsening renal function with rivaroxaban compared with warfarin",
        "Renal function and treatment persistence with non-vitamin K antagonist oral anticoagulants in Japanese patients with atrial fibrillation: a single-center experience",
        "Acute kidney injury in Asians with atrial fibrillation treated with dabigatran or warfarin",
        "Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation",
        "Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial",
        "Direct oral anticoagulants and risk of acute kidney injury in patients with atrial fibrillation",
        "Rivaroxaban versus warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes",
        "Distribution of thromboembolism in valvular versus non-valvular atrial fibrillation",
        "A survey of reasons for continuing warfarin therapy in the era of direct oral anticoagulants in Japanese patients with atrial fibrillation: the SELECT study",
        "Trends in warfarin use and its associations with thromboembolic and bleeding rates in a population with atrial fibrillation between 1996 and 2011",
        "Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases",
        "5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy",
        "Warfarin-related nephropathy is the tip of the iceberg: direct thrombin inhibitor dabigatran induces glomeru-lar hemorrhage with acute kidney injury in rats",
        "Warfarin-related ne-phropathy induced by three different vitamin K antagonists: analysis of 13 biopsy-proven cases",
        "Acute mmune-allergic interstitial nephritis after treatment with fluindione. Seven cases",
        "Incidence of severe renal dysfunction among individuals taking warfarin and implications for non-vitamin K oral anticoagulants",
        "Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate",
        "Incidence of severe renal dysfunction among individuals taking warfarin and implications for non\u2013vitamin K oral anticoagulants",
        "Pharmacokinetic drug interactions of the non-vitamin K antagonist oral anticoagulants (NOACs)",
        "Acute kidney injury aggravated by treatment initiation with apixaban: another twist of anticoagulant-related nephropathy",
        "Dabigatran-induced nephropathy and its successful treatment with Idarucizumab\u2014case report and literature review",
        "Direct oral anticoagulant and AKI: apixaban-induced acute interstitial nephritis",
        "Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein",
        "Vascular calcification: the price to pay for anticoagulation therapy with vitamin K-antagonists",
        "Differential contribution of Fxa and thrombin to vascular inflammation in a mouse model of sickle cell disease",
        "Renoprotective effects of a factor Xa inhibitor: fusion of basic research and a database analysis",
        "The effects of direct thrombin inhibition with dabigatran on plaque formation and en-dothelial function in apolipoprotein E-deficient mice"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60013939",
            "affilname": "Faculty of Medicine, Thammasat University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013939",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}